Advanced BioDesign is a French biotechnology company that is developing a new innovative targeted therapy against resistant cancers, with a first indication in acute myeloid leukemia (AML). Its main anticancer compound, DIMATE (ABD-3001), is a first-in-class suicide inhibitor of aldehyde dehydrogenases 1 & 3 (ALDH1 & 3). By inhibiting this enzyme, ABD-3001 causes cancer cell apoptosis without damaging healthy cells.
655 ALLEE DES PARCS – BATIMENT D – 69800 SAINT-PRIEST
Targeted indications : Cancer du sein, Cancer du poumon, Cancer de la peau, Cancer hématologique